FilingReader Intelligence
Adcock Ingram reports strong second half, announces acquisition
August 22, 2025 at 05:39 AM UTC•By FilingReader AI
Adcock Ingram reported 1% revenue growth to R9.76bn for the year ended June 30, 2025. The second half saw a 30% improvement in trading profit and 36% rise in headline earnings per share compared to the first half.
NATCO Pharma will acquire all shares not owned by Bidvest, leading to delisting from the JSE.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
JSE:AIP•Johannesburg Stock Exchange
News Alerts
Get instant email alerts when ADCOCK INGRAM HOLDINGS LIMITED publishes news
Free account required • Unsubscribe anytime